These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 8818906)

  • 21. Comparison of Clinical Laboratory Standards Institute and European Committee on Antimicrobial Susceptibility Testing guidelines for the interpretation of antibiotic susceptibility at a University teaching hospital in Nairobi, Kenya: a cross-sectional study.
    Kassim A; Omuse G; Premji Z; Revathi G
    Ann Clin Microbiol Antimicrob; 2016 Apr; 15():21. PubMed ID: 27068515
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Validation of cefditoren MIC quality control ranges by a multi-laboratory study (2001).
    Jones RN; Biedenbach DJ;
    Diagn Microbiol Infect Dis; 2001; 40(1-2):71-3. PubMed ID: 11448567
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Determination of MIC Quality Control Parameters for Exebacase, a Novel Lysin with Antistaphylococcal Activity.
    Traczewski MM; Ambler JE; Schuch R
    J Clin Microbiol; 2021 Jun; 59(7):e0311720. PubMed ID: 33910968
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Newly defined in vitro quality control ranges for oritavancin broth microdilution testing and impact of variation in testing parameters.
    Arhin FF; Tomfohrde K; Draghi DC; Aranza M; Parr TR; Sahm DF; Moeck G
    Diagn Microbiol Infect Dis; 2008 Sep; 62(1):92-5. PubMed ID: 18614315
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Selection of candidate quality control isolates and tentative quality control ranges for in vitro susceptibility testing of yeast isolates by National Committee for Clinical Laboratory Standards proposed standard methods.
    Pfaller MA; Bale M; Buschelman B; Lancaster M; Espinel-Ingroff A; Rex JH; Rinaldi MG
    J Clin Microbiol; 1994 Jul; 32(7):1650-3. PubMed ID: 7929752
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Development of interpretive criteria and quality control limits for macrolide and clindamycin susceptibility testing of Streptococcus pneumoniae.
    Jorgensen JH; Swenson JM; Tenover FC; Barry A; Ferraro MJ; Murray PR; Reller LB
    J Clin Microbiol; 1996 Nov; 34(11):2679-84. PubMed ID: 8897164
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ofloxacin susceptibility testing quality control parameters for microdilution and disk diffusion, and confirmation of disk diffusion interpretive criteria.
    Fuchs PC; Jones RN; Barry AL; Gavan TL
    J Clin Microbiol; 1989 Jan; 27(1):49-52. PubMed ID: 2492304
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Quality control guidelines for National Committee for Clinical Laboratory Standards--recommended broth macrodilution testing of ketoconazole and itraconazole.
    Rex JH; Pfaller MA; Lancaster M; Odds FC; Bolmström A; Rinaldi MG
    J Clin Microbiol; 1996 Apr; 34(4):816-7. PubMed ID: 8815089
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Contemporary assessment of antimicrobial susceptibility testing methods for polymyxin B and colistin: review of available interpretative criteria and quality control guidelines.
    Gales AC; Reis AO; Jones RN
    J Clin Microbiol; 2001 Jan; 39(1):183-90. PubMed ID: 11136768
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Gatifloxacin (AM-1155, CG 5501) susceptibility testing interpretive criteria and quality control guidelines for dilution and disk (5-microgram) diffusion methods. The Quality Control Study Group.
    Jones RN; Kugler KC; Erwin ME; Biedenbach DJ; Beach ML; Pfaller MA
    Diagn Microbiol Infect Dis; 1999 Apr; 33(4):247-53. PubMed ID: 10212751
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antimicrobial susceptibility of microorganisms isolated from the mammary glands of dairy heifers.
    Watts JL; Salmon SA; Yancey RJ; Nickerson SC; Weaver LJ; Holmberg C; Pankey JW; Fox LK
    J Dairy Sci; 1995 Jul; 78(7):1637-48. PubMed ID: 7593859
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antimicrobial activity and spectrum of SCH27899 (Ziracin) tested against gram-positive species including recommendations for routine susceptibility testing methods and quality control. Quality Control Study Group.
    Jones RN; Marshall SA; Erwin ME
    Diagn Microbiol Infect Dis; 1999 Jun; 34(2):103-10. PubMed ID: 10354859
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Quality control guidelines for testing gram-negative control strains with polymyxin B and colistin (polymyxin E) by standardized methods.
    Jones RN; Anderegg TR; Swenson JM;
    J Clin Microbiol; 2005 Feb; 43(2):925-7. PubMed ID: 15695708
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of the agar dilution, tube dilution, and broth microdilution susceptibility tests for determination of teicoplanin MICs.
    Kenny MT; Dulworth JK; Brackman MA
    J Clin Microbiol; 1989 Jun; 27(6):1409-10. PubMed ID: 2526821
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prediction of piperacillin-tazobactam susceptibility among Enterobacteriaceae, Pseudomonas aeruginosa, and other bacteria using ticarcillin-clavulanic acid, ceftazidime, and other broad-spectrum antimicrobial in vitro test results.
    Jones RN; Sutton LD; Cantrell HF; Lankford RB
    Diagn Microbiol Infect Dis; 1994 Nov; 20(3):143-9. PubMed ID: 7874881
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Quality control guidelines for National Committee for Clinical Laboratory Standards recommended broth macrodilution testing of amphotericin B, fluconazole, and flucytosine.
    Pfaller MA; Bale M; Buschelman B; Lancaster M; Espinel-Ingroff A; Rex JH; Rinaldi MG; Cooper CR; McGinnis MR
    J Clin Microbiol; 1995 May; 33(5):1104-7. PubMed ID: 7615713
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparative antimicrobial activity of gatifloxacin tested against Streptococcus spp. including quality control guidelines and etest method validation. Quality Control Study Group.
    Jones RN; Johnson DM; Erwin ME; Beach ML; Biedenbach DJ; Pfaller MA
    Diagn Microbiol Infect Dis; 1999 Jun; 34(2):91-8. PubMed ID: 10354857
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Determination of Disk Diffusion and MIC Quality Control Ranges for Nafithromycin (WCK 4873), a New Lactone-Ketolide.
    Hackel MA; Karlowsky JA; Dressel D; Sahm DF
    J Clin Microbiol; 2017 Oct; 55(10):3021-3027. PubMed ID: 28747372
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Quality control ranges for testing broth microdilution susceptibility of Flavobacterium columnare and F. psychrophilum to nine antimicrobials.
    Gieseker CM; Mayer TD; Crosby TC; Carson J; Dalsgaard I; Darwish AM; Gaunt PS; Gao DX; Hsu HM; Lin TL; Oaks JL; Pyecroft M; Teitzel C; Somsiri T; Wu CC
    Dis Aquat Organ; 2012 Nov; 101(3):207-15. PubMed ID: 23324417
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The Calgary Biofilm Device: new technology for rapid determination of antibiotic susceptibilities of bacterial biofilms.
    Ceri H; Olson ME; Stremick C; Read RR; Morck D; Buret A
    J Clin Microbiol; 1999 Jun; 37(6):1771-6. PubMed ID: 10325322
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.